HSFY2
gene geneOn this page
Also known as FLJ25453
Summary
HSFY2 (heat shock transcription factor Y-linked 2, HGNC:23950) is a protein-coding gene on chromosome Yq11.222, encoding Heat shock transcription factor, Y-linked (Q96LI6).
This gene encodes a member of the heat shock factor (HSF) family of transcriptional activators for heat shock proteins. This gene is a candidate gene for azoospermia, since it localizes to a region of chromosome Y that is sometimes deleted in infertile males. The genome has two identical copies of this gene within a palindromic region; this record represents the more telomeric copy. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
Source: NCBI Gene 159119 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_153716
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23950 |
| Approved symbol | HSFY2 |
| Name | heat shock transcription factor Y-linked 2 |
| Location | Yq11.222 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25453 |
| Ensembl gene | ENSG00000169953 |
| Ensembl biotype | protein_coding |
| Entrez | 159119 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000304790, ENST00000344884, ENST00000382852, ENST00000491902
RefSeq mRNA: 2 — MANE Select: NM_153716
NM_001001877, NM_153716
CCDS: CCDS14791, CCDS35476
Canonical transcript exons
ENST00000304790 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001674814 | 18773106 | 18773735 |
| ENSE00001858694 | 18771814 | 18772627 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 71.22.
Top tissues by expression
115 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 71.22 | gold quality |
| testis | UBERON:0000473 | 70.06 | gold quality |
| left testis | UBERON:0004533 | 69.61 | gold quality |
| right testis | UBERON:0004534 | 64.65 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 56.53 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 48.30 | gold quality |
| hypothalamus | UBERON:0001898 | 46.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 43.77 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 43.71 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 43.56 | gold quality |
| cerebellar cortex | UBERON:0002129 | 43.24 | gold quality |
| cerebellum | UBERON:0002037 | 42.92 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 41.76 | gold quality |
| primary visual cortex | UBERON:0002436 | 40.68 | gold quality |
| nucleus accumbens | UBERON:0001882 | 40.46 | gold quality |
| cerebral cortex | UBERON:0000956 | 39.62 | gold quality |
| metanephros cortex | UBERON:0010533 | 39.44 | gold quality |
| right frontal lobe | UBERON:0002810 | 39.27 | gold quality |
| putamen | UBERON:0001874 | 39.09 | gold quality |
| cortex of kidney | UBERON:0001225 | 39.05 | gold quality |
| brain | UBERON:0000955 | 38.76 | gold quality |
| caudate nucleus | UBERON:0001873 | 38.52 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.61 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| Ammon’s horn | UBERON:0001954 | 35.79 | gold quality |
| substantia nigra | UBERON:0002038 | 35.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting HSFY2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-1273H-3P | 99.29 | 67.55 | 980 |
| HSA-MIR-296-3P | 99.21 | 66.56 | 474 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-6755-3P | 98.61 | 66.90 | 834 |
| HSA-MIR-6852-3P | 98.54 | 67.60 | 1468 |
| HSA-MIR-3909 | 97.55 | 66.78 | 887 |
| HSA-MIR-4474-5P | 94.23 | 67.95 | 568 |
Literature-anchored findings (GeneRIF, showing 1)
- Could have an important role in human spermatogenesis. (PMID:14985478)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hsfy2 | ENSMUSG00000045336 |
| rattus_norvegicus | Hsfy2 | ENSRNOG00000038569 |
| drosophila_melanogaster | Hsf | FBGN0001222 |
| caenorhabditis_elegans | hsf-1 | WBGENE00002004 |
Paralogs (9): HSF2 (ENSG00000025156), HSF4 (ENSG00000102878), HSFX1 (ENSG00000171116), HSFY1 (ENSG00000172468), HSF5 (ENSG00000176160), HSF1 (ENSG00000185122), HSFX2 (ENSG00000268738), HSFX4 (ENSG00000283463), HSFX3 (ENSG00000283697)
Protein
Protein identifiers
Heat shock transcription factor, Y-linked — Q96LI6 (reviewed: Q96LI6)
Alternative names: Heat shock transcription factor 2-like protein
All UniProt accessions (1): Q96LI6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Testis-specific. Present in Sertoli cells and spermatogenic cells (at protein level).
Similarity. Belongs to the HSF family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96LI6-1 | 1 | yes |
| Q96LI6-2 | 2 | |
| Q96LI6-3 | 3 |
RefSeq proteins (2): NP_001001877, NP_714927* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000232 | HSF_DNA-bd | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
Pfam: PF00447
UniProt features (10 total): splice variant 4, sequence conflict 2, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LI6-F1 | 58.77 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrYq11, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR548AZ_5P, MIR548T_5P, MIR4311, MIR6134, MIR885_5P, GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN, GOCC_CHROMATIN, GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (5): chromatin (GO:0000785), nucleoplasm (GO:0005654), cytosol (GO:0005829), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
670 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HSFY2 | TSPY1 | P09002 | 772 |
| HSFY2 | RBMY1A1 | P0DJD3 | 769 |
| HSFY2 | BPY2 | O14599 | 762 |
| HSFY2 | CDY2A | Q9Y6F7 | 761 |
| HSFY2 | VCY | O14598 | 720 |
| HSFY2 | CDY1 | Q9Y6F8 | 714 |
| HSFY2 | DAZ1 | Q9NQZ3 | 707 |
| HSFY2 | USP9Y | O00507 | 692 |
| HSFY2 | PRY | O14603 | 691 |
| HSFY2 | RPS4Y2 | Q8TD47 | 634 |
| HSFY2 | ZFY | P08048 | 624 |
| HSFY2 | DDX3Y | O15523 | 623 |
| HSFY2 | EIF1AY | O14602 | 606 |
| HSFY2 | KDM5D | Q9BY66 | 597 |
| HSFY2 | RPS4Y1 | P22090 | 585 |
IntAct
96 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GCM2 | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.890 |
| HSFY1 | GCM2 | psi-mi:“MI:0915”(physical association) | 0.890 |
| TBX6 | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| HSFY1 | TBX6 | psi-mi:“MI:0915”(physical association) | 0.780 |
| HSFY1 | RBM47 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSFY1 | SOX15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSFY1 | HNRNPF | psi-mi:“MI:0915”(physical association) | 0.560 |
| QRICH1 | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SV2B | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM47 | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPF | HSFY1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (62): HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (Two-hybrid), HSFY1 (PCA), HSFY1 (Two-hybrid), TUBA3C (Affinity Capture-MS), SATB2 (Affinity Capture-MS), POTEF (Affinity Capture-MS), CHD4 (Affinity Capture-MS), CHD3 (Affinity Capture-MS), MIS12 (Affinity Capture-MS)
ESM2 similar proteins: B0FZN7, B0FZN8, B0FZN9, B0FZP0, B0FZP1, B0FZP2, B0FZP3, F4JYG0, O57437, P11308, P26323, P41157, P81270, Q01543, Q0DKP4, Q14B70, Q21263, Q24207, Q29RS8, Q4R361, Q4V7Y4, Q503H1, Q5ZKW8, Q64368, Q69V10, Q6F2E2, Q6R0H0, Q71RC2, Q75M35, Q76CY5, Q7Z353, Q804A9, Q80YT9, Q8K402, Q8N9W6, Q8W4I9, Q8WP23, Q90837, Q924M5, Q92904
Diamond homologs: A0A1B0GTS1, A0A1B0GWH4, B7XIV9, C4V6H6, D0VYS2, G0SB31, G5EFT5, J9VHZ9, O14283, O49403, P10961, P22121, P22335, P22813, P38529, P38530, P38531, P38532, P38533, P41151, P41153, P41154, Q00613, Q02953, Q03933, Q08DJ8, Q10PR4, Q1HGE8, Q1PDN3, Q338B0, Q40152, Q4G112, Q5A4X5, Q5AQ33, Q5CZP2, Q5KMX8, Q5ND04, Q652B0, Q67TP9, Q6F388
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
96 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:18772628:C:CC | acceptor_gain | 0.9900 |
| Y:18773101:AATAC:A | donor_loss | 0.9900 |
| Y:18773102:ATAC:A | donor_loss | 0.9900 |
| Y:18773103:TA:T | donor_loss | 0.9900 |
| Y:18773104:A:AT | donor_loss | 0.9900 |
| Y:18773105:C:A | donor_loss | 0.9900 |
| Y:18773105:CCTTG:C | donor_gain | 0.9800 |
| Y:18772623:TTTAA:T | acceptor_gain | 0.9600 |
| Y:18773106:C:G | donor_loss | 0.9500 |
| Y:18772624:TTAA:T | acceptor_gain | 0.9400 |
| Y:18772625:TAA:T | acceptor_gain | 0.8900 |
| Y:18772625:TAAC:T | acceptor_loss | 0.8600 |
| Y:18772627:ACTAA:A | acceptor_loss | 0.8600 |
| Y:18772630:A:C | acceptor_loss | 0.8300 |
| Y:18773070:CT:C | donor_gain | 0.8300 |
| Y:18773071:TT:T | donor_gain | 0.8300 |
| Y:18773072:TT:T | donor_gain | 0.8300 |
| Y:18773109:G:A | donor_gain | 0.8300 |
| Y:18773467:A:AC | donor_gain | 0.8200 |
| Y:18773469:A:T | donor_gain | 0.8200 |
| Y:18772626:AA:A | acceptor_gain | 0.8100 |
| Y:18773092:A:C | donor_gain | 0.8100 |
| Y:18773466:CA:C | donor_gain | 0.7900 |
| Y:18773468:AA:A | donor_gain | 0.7900 |
| Y:18772631:AAA:A | acceptor_loss | 0.7000 |
| Y:18772141:CATTT:C | acceptor_gain | 0.6900 |
| Y:18772632:A:C | acceptor_loss | 0.6600 |
| Y:18773100:AAAT:A | donor_loss | 0.6600 |
| Y:18772635:C:CT | acceptor_gain | 0.6400 |
| Y:18773191:AAT:A | donor_gain | 0.6400 |
AlphaMissense
2620 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:18773190:A:C | F143L | 0.993 |
| Y:18773190:A:T | F143L | 0.993 |
| Y:18773192:A:G | F143L | 0.993 |
| Y:18773327:A:G | W98R | 0.990 |
| Y:18773327:A:T | W98R | 0.990 |
| Y:18773325:C:A | W98C | 0.989 |
| Y:18773325:C:G | W98C | 0.989 |
| Y:18773191:A:G | F143S | 0.981 |
| Y:18772601:G:C | F180L | 0.980 |
| Y:18772601:G:T | F180L | 0.980 |
| Y:18772603:A:G | F180L | 0.980 |
| Y:18772602:A:G | F180S | 0.978 |
| Y:18773326:C:G | W98S | 0.973 |
| Y:18773379:A:C | F80L | 0.971 |
| Y:18773379:A:T | F80L | 0.971 |
| Y:18773381:A:G | F80L | 0.971 |
| Y:18773241:A:C | F126L | 0.967 |
| Y:18773241:A:T | F126L | 0.967 |
| Y:18773243:A:G | F126L | 0.967 |
| Y:18773206:A:G | L138P | 0.966 |
| Y:18773284:A:G | F112S | 0.958 |
| Y:18773242:A:G | F126S | 0.956 |
| Y:18773206:A:T | L138H | 0.952 |
| Y:18773368:A:T | L84H | 0.952 |
| Y:18772618:A:C | Y175D | 0.950 |
| Y:18773340:G:C | F93L | 0.950 |
| Y:18773340:G:T | F93L | 0.950 |
| Y:18773342:A:G | F93L | 0.950 |
| Y:18773212:C:G | R136P | 0.949 |
| Y:18773299:A:C | I107S | 0.949 |
dbSNP variants (sampled 300 via entrez): RS111359694 (Y:18788648 G>C), RS113200071 (Y:18785109 A>C), RS113420648 (Y:18780608 T>A), RS113534513 (Y:18783474 A>G), RS113957233 (Y:18791384 G>C), RS1166542042 (Y:18785102 C>T), RS1173265774 (Y:18770299 G>A), RS1183125141 (Y:18733720 C>T), RS1184683725 (Y:18770182 C>T), RS1249496725 (Y:18733561 C>A), RS1309474642 (Y:18788730 C>A), RS1353113901 (Y:18788882 T>A), RS1366821706 (Y:18786307 T>A), RS1396199958 (Y:18785445 A>G), RS1397029336 (Y:18770218 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A3C6 | SEES3-1V human HSFY2, clone1 | Embryonic stem cell | Male |
| CVCL_A3C7 | SEES3-1V human HSFY2, clone2 | Embryonic stem cell | Male |
| CVCL_A3C8 | SEES3-1V human HSFY2, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.